Health Care & Life Sciences » Pharmaceuticals | Ionis Pharmaceuticals Inc.

Ionis Pharmaceuticals Inc. | Ownership

Companies that own Ionis Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Fidelity Management & Research Co.
18,819,457
13.71%
17,575
0.09%
06/30/2018
The Vanguard Group, Inc.
10,860,447
7.91%
557,744
0.02%
06/30/2018
ClearBridge Investments LLC
10,820,120
7.88%
-99,989
0.42%
06/30/2018
Baillie Gifford & Co.
9,279,730
6.76%
3,017,079
0.26%
06/30/2018
Wellington Management Co. LLP
9,248,361
6.74%
-705,581
0.08%
06/30/2018
Bellevue Asset Management AG
8,988,920
6.55%
160,400
5.93%
06/30/2018
BlackRock Fund Advisors
6,472,787
4.72%
-119,818
0.02%
06/30/2018
Waddell & Reed Investment Management Co.
4,530,100
3.3%
0
0.36%
06/30/2018
SSgA Funds Management, Inc.
3,059,018
2.23%
93,771
0.01%
06/30/2018
OppenheimerFunds, Inc.
2,932,050
2.14%
57,025
0.08%
06/30/2018

About Ionis Pharmaceuticals

View Profile
Address
2855 Gazelle Court
Carlsbad California 92010
United States
Employees -
Website http://www.ionispharm.com
Updated 07/08/2019
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.